Anatara Lifesciences Ltd (ANR.AX)
AUD 0.01
(0.0%)
AUD 0.01
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 306.84 Thousand AUD | -37.99% |
| 2023 | 494.83 Thousand AUD | 22.68% |
| 2022 | 403.35 Thousand AUD | -18.79% |
| 2021 | 496.67 Thousand AUD | 1.99% |
| 2020 | 486.96 Thousand AUD | 4.33% |
| 2019 | 466.75 Thousand AUD | -61.9% |
| 2018 | 1.22 Million AUD | 314.62% |
| 2017 | 295.43 Thousand AUD | -33.55% |
| 2016 | 444.61 Thousand AUD | 202.51% |
| 2015 | 146.97 Thousand AUD | -35.43% |
| 2014 | 227.61 Thousand AUD | -35.51% |
| 2013 | 352.95 Thousand AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q4 | 306.84 Thousand AUD | 0.0% |
| 2024 FY | 306.84 Thousand AUD | -37.99% |
| 2024 Q2 | 162.6 Thousand AUD | 0.0% |
| 2023 Q4 | 494.83 Thousand AUD | 0.0% |
| 2023 FY | 494.83 Thousand AUD | 22.68% |
| 2023 Q2 | 242.05 Thousand AUD | 0.0% |
| 2022 Q4 | 403.35 Thousand AUD | 0.0% |
| 2022 Q2 | 478.15 Thousand AUD | 0.0% |
| 2022 FY | 403.35 Thousand AUD | -18.79% |
| 2021 Q2 | 265.27 Thousand AUD | 0.0% |
| 2021 Q4 | 496.67 Thousand AUD | 0.0% |
| 2021 FY | 496.67 Thousand AUD | 1.99% |
| 2020 Q2 | 521.3 Thousand AUD | 0.0% |
| 2020 FY | 486.96 Thousand AUD | 4.33% |
| 2020 Q4 | 486.96 Thousand AUD | 0.0% |
| 2019 FY | 466.75 Thousand AUD | -61.9% |
| 2019 Q4 | 466.75 Thousand AUD | 0.0% |
| 2019 Q2 | 651.92 Thousand AUD | 0.0% |
| 2018 Q2 | 409.22 Thousand AUD | 0.0% |
| 2018 FY | 1.22 Million AUD | 314.62% |
| 2018 Q4 | 1.22 Million AUD | 0.0% |
| 2017 Q2 | 292.17 Thousand AUD | 0.0% |
| 2017 Q4 | 295.43 Thousand AUD | 0.0% |
| 2017 FY | 295.43 Thousand AUD | -33.55% |
| 2016 FY | 444.61 Thousand AUD | 202.51% |
| 2016 Q2 | 126.04 Thousand AUD | 0.0% |
| 2016 Q4 | 444.61 Thousand AUD | 0.0% |
| 2015 Q2 | 53.18 Thousand AUD | 0.0% |
| 2015 FY | 146.97 Thousand AUD | -35.43% |
| 2015 Q4 | 146.97 Thousand AUD | 0.0% |
| 2014 FY | 227.61 Thousand AUD | -35.51% |
| 2014 Q4 | 227.61 Thousand AUD | 0.0% |
| 2014 Q3 | 227.61 Thousand AUD | 0.0% |
| 2013 FY | 352.95 Thousand AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AdAlta Limited | 3.54 Million AUD | 91.338% |
| Acrux Limited | 5.68 Million AUD | 94.604% |
| Actinogen Medical Limited | 1.61 Million AUD | 81.004% |
| AnteoTech Limited | 4.07 Million AUD | 92.47% |
| Argenica Therapeutics Limited | 2.42 Million AUD | 87.355% |
| Arovella Therapeutics Limited | 2.05 Million AUD | 85.08% |
| Alterity Therapeutics Limited | 5.42 Million AUD | 94.345% |
| Amplia Therapeutics Limited | 3.42 Million AUD | 91.046% |
| Avecho Biotechnology Limited | 941.54 Thousand AUD | 67.41% |
| Bio-Gene Technology Limited | 368.44 Thousand AUD | 16.718% |
| Biome Australia Limited | 5.37 Million AUD | 94.289% |
| Biotron Limited | 737.5 Thousand AUD | 58.394% |
| Botanix Pharmaceuticals Limited | 3.73 Million AUD | 91.778% |
| BTC Health Limited | 203.94 Thousand AUD | -50.455% |
| Chimeric Therapeutics Limited | 12.8 Million AUD | 97.603% |
| CSL Limited | 27.88 Billion AUD | 99.999% |
| Clarity Pharmaceuticals Ltd | 8.33 Million AUD | 96.317% |
| Clinuvel Pharmaceuticals Limited | 28.11 Million AUD | 98.908% |
| Cynata Therapeutics Limited | 1.17 Million AUD | 73.797% |
| Dimerix Limited | 13.89 Million AUD | 97.791% |
| EZZ Life Science Holdings Limited | 4.22 Million AUD | 92.744% |
| Hexima Limited | 248.67 Thousand AUD | -23.396% |
| Island Pharmaceuticals Limited | 1.04 Million AUD | 70.654% |
| Immuron Limited | 2.84 Million AUD | 89.197% |
| Immutep Limited | 10.97 Million AUD | 97.205% |
| Imugene Limited | 33.14 Million AUD | 99.074% |
| Invex Therapeutics Ltd | 431.63 Thousand AUD | 28.909% |
| Memphasys Limited | 5.59 Million AUD | 94.513% |
| Nanollose Limited | 465.64 Thousand AUD | 34.102% |
| Neuren Pharmaceuticals Limited | 42.76 Million AUD | 99.282% |
| Noxopharm Limited | 1.28 Million AUD | 76.188% |
| NeuroScientific Biopharmaceuticals Limited | 85.68 Thousand AUD | -258.121% |
| Nyrada Inc. | 855.63 Thousand AUD | 64.138% |
| Orthocell Limited | 22.08 Million AUD | 98.61% |
| PharmAust Limited | 896.6 Thousand AUD | 65.777% |
| Patrys Limited | 691.36 Thousand AUD | 55.617% |
| Paradigm Biopharmaceuticals Limited | 3.58 Million AUD | 91.439% |
| Proteomics International Laboratories Limited | 1.62 Million AUD | 81.128% |
| Prescient Therapeutics Limited | 2.32 Million AUD | 86.805% |
| PYC Therapeutics Limited | 10.18 Million AUD | 96.987% |
| Race Oncology Limited | 1.91 Million AUD | 83.988% |
| Radiopharm Theranostics Limited | 44.68 Million AUD | 99.313% |
| Recce Pharmaceuticals Ltd | 15.89 Million AUD | 98.069% |
| Starpharma Holdings Limited | 8.69 Million AUD | 96.472% |
| Telix Pharmaceuticals Limited | 249.39 Million AUD | 99.877% |
| Tissue Repair Ltd | 1.35 Million AUD | 77.286% |
| Zelira Therapeutics Limited | 9.35 Million AUD | 96.721% |